<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>IBS &#8211; Reflux Care of New York</title>
	<atom:link href="http://refluxny.com/tag/ibs/feed/" rel="self" type="application/rss+xml" />
	<link>http://refluxny.com</link>
	<description>Long Island&#039;s Leading Center for Gastroesophageal Reflux Disease , Laryngopharyngeal Reflux, Eosinophilic Esophagitis and Irritable Bowel Syndrome</description>
	<lastBuildDate>
	Wed, 18 Dec 2019 05:26:05 +0000	</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>Irritable Bowel Syndrome &#124; IBS</title>
		<link>http://refluxny.com/irritable-bowel-syndrome/</link>
				<comments>http://refluxny.com/irritable-bowel-syndrome/#respond</comments>
				<pubDate>Thu, 15 Nov 2012 22:35:44 +0000</pubDate>
		<dc:creator><![CDATA[Dr. David Gutman]]></dc:creator>
				<category><![CDATA[Default]]></category>
		<category><![CDATA[IBS]]></category>
		<category><![CDATA[abdominal pain]]></category>
		<category><![CDATA[Irritable Bowel Syndrome]]></category>

		<guid isPermaLink="false">http://refluxny.com/?page_id=597</guid>
				<description><![CDATA[<p>What You Do Not Know About Irritable Bowel Syndrome Can Affect Your Health. Discover the mistakes physicians and patients make. These shocking facts can protect your life. </p>
<p>The post <a rel="nofollow" href="http://refluxny.com/irritable-bowel-syndrome/">Irritable Bowel Syndrome | IBS</a> appeared first on <a rel="nofollow" href="http://refluxny.com">Reflux Care of New York</a>.</p>
]]></description>
						<wfw:commentRss>http://refluxny.com/irritable-bowel-syndrome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
							</item>
		<item>
		<title>Irritable Bowel Syndrome Treatment for Patients With Diarrhea and Abdominal Pain Offers New Opportunity for Relief</title>
		<link>http://refluxny.com/irritable-bowel-syndrome-treatment/</link>
				<comments>http://refluxny.com/irritable-bowel-syndrome-treatment/#respond</comments>
				<pubDate>Mon, 05 Nov 2012 01:05:38 +0000</pubDate>
		<dc:creator><![CDATA[Dr. David Gutman]]></dc:creator>
				<category><![CDATA[Default]]></category>
		<category><![CDATA[IBS]]></category>
		<category><![CDATA[abdominal pain]]></category>
		<category><![CDATA[diarrhea]]></category>
		<category><![CDATA[Irritable Bowel Syndrome]]></category>
		<category><![CDATA[research]]></category>

		<guid isPermaLink="false">http://refluxny.com/?p=54</guid>
				<description><![CDATA[<p>Clinical studies are being performed to determine relief and symptom control for  a new diarrhea predominant Irritable Bowel Syndrome treatment. </p>
<p>The post <a rel="nofollow" href="http://refluxny.com/irritable-bowel-syndrome-treatment/">Irritable Bowel Syndrome Treatment for Patients With Diarrhea and Abdominal Pain Offers New Opportunity for Relief</a> appeared first on <a rel="nofollow" href="http://refluxny.com">Reflux Care of New York</a>.</p>
]]></description>
						<wfw:commentRss>http://refluxny.com/irritable-bowel-syndrome-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
							</item>
		<item>
		<title>Research Performed at Progressive Gastroenterology Leads to FDA Approval of Linzess (Linaclotide) for the Treatment of Irritable Bowel Syndrome and Chronic Constipation</title>
		<link>http://refluxny.com/constipation-irritable-bowel-syndrome-linzess/</link>
				<comments>http://refluxny.com/constipation-irritable-bowel-syndrome-linzess/#respond</comments>
				<pubDate>Sun, 04 Nov 2012 21:40:49 +0000</pubDate>
		<dc:creator><![CDATA[Dr. David Gutman]]></dc:creator>
				<category><![CDATA[Default]]></category>
		<category><![CDATA[IBS]]></category>
		<category><![CDATA[constipation]]></category>
		<category><![CDATA[Irritable Bowel Syndrome]]></category>
		<category><![CDATA[linaclotide]]></category>
		<category><![CDATA[Linzess]]></category>
		<category><![CDATA[Progressive Gastroenterology]]></category>
		<category><![CDATA[research]]></category>

		<guid isPermaLink="false">http://refluxny.com/?p=48</guid>
				<description><![CDATA[<p>Linzess (Linaclotide) has been shown to be safe and effective for Constipation Predominant Irritable Bowel Syndrome (IBS-C) and Chronic Constipation (CC). </p>
<p>The post <a rel="nofollow" href="http://refluxny.com/constipation-irritable-bowel-syndrome-linzess/">Research Performed at Progressive Gastroenterology Leads to FDA Approval of Linzess (Linaclotide) for the Treatment of Irritable Bowel Syndrome and Chronic Constipation</a> appeared first on <a rel="nofollow" href="http://refluxny.com">Reflux Care of New York</a>.</p>
]]></description>
						<wfw:commentRss>http://refluxny.com/constipation-irritable-bowel-syndrome-linzess/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
							</item>
	</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.w3-edge.com/products/

Page Caching using disk: enhanced 

Served from: refluxny.com @ 2026-04-17 05:01:39 by W3 Total Cache
-->